ArticleJournal of clinical immunology2010

TL1A selectively enhances IL-12/IL-18-induced NK cell cytotoxicity against NK-resistant tumor targets.

Stephanie C Heidemann et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.